#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Rett syndrome Complex regional pain syndrome X-linked lymphoproliferative syndrome Intracranial germ cell tumour Hypochondroplasia Cataract Retinitis pigmentosa Von Hippel-Lindau disease Cutaneous lupus erythematosus Inflammatory myofibroblastic tumour Paroxysmal nocturnal haemoglobinuria Uterine leiomyosarcoma Ocular myasthenia Alexander disease Leiomyosarcoma More trials…

    Learn about Rare Diseases

    Factor VIII deficiency – Life with Disease Mast cell activation syndrome – Trials in Disease Loeys-Dietz syndrome – Diagnostics Rosai-Dorfman syndrome – Trials in Disease Familial amyotrophic lateral sclerosis – Basic Information Breast angiosarcoma metastatic – Trials in Disease Krabbe’s disease – Life with Disease Alternating hemiplegia of childhood – Life with Disease Erdheim-Chester disease – Life with Disease Leiomyosarcoma recurrent – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Proguanil Hydrochloride IHMA-2121908-1 Zanidatamab Ciclosporin A Lamotrigine Montelukast Corifollitropin Alfa Andexanet Alfa GS-1720 Padeliporfin D,L-Lysine Acetylsalicylate Botulinum Toxin Type A Idelalisib Ergocalciferol Bp Mifepristone SAROGLITAZAR HEMIMAGNESIUM Caspofungin Flecainide Amikacin Sulfate Bleomycin Sulfate More therapies…

    Learn about Your Condition

    Peripheral spondyloarthritis Inguinal hernia Anal squamous cell carcinoma Gaucher's disease type I Myeloproliferative neoplasm Hypertension Fibrosarcoma metastatic Electrocorticogram Mantle cell lymphoma recurrent Brain injury Rett syndrome Metastatic glioma Abdominal wall pain Gastrointestinal melanoma Chondropathy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study comparing RMC-6236 and docetaxel in previously treated patients with advanced or metastatic non-small cell lung cancer who have RAS mutations

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • (12M)-(1S,2S)-N-((63S,4S,Z)-11-ETHYL-12-(2-((S)-1-METHOXYETHYL)-5-(4-METHYLPIPERAZIN-1-YL)PYRIDIN-3-YL)-10,10-DIMETHYL-5,7-DIOXO-61,62,63,64,65,66-HEXAHYDRO-11H-8-OXA-2(4,2)-THIAZOLA-1(5,3)-INDOLA-6(1,3)-PYRIDAZINACYCLOUNDECAPHANE-4-YL)-2-METHYLCYCLOPROPANE-1-CARBOXAMIDE
    • Docetaxel
    Belgium France Germany Ireland Italy The Netherlands +2

  • Study of PF-07275315 to evaluate its effectiveness and safety in adults with moderate-to-severe asthma who have high levels of eosinophils in their blood

    Recruiting

    2 1
    Investigated Diseases:
    • Asthma
    Belgium Bulgaria Czechia Hungary Italy Poland +1

  • Study of Lutetium-177-PSMA treatment for patients with advanced clear cell kidney cancer who had progression after first or second line therapy

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lutetium (177Lu) Vipivotide Tetraxetan
    Belgium France Spain

  • Study of rilzabrutinib tablets compared to placebo in adults with warm autoimmune hemolytic anemia

    Recruiting

    3 1
    Investigated Diseases:
    • Autoimmune haemolytic anaemia
    Investigated Drugs:
    • Rilzabrutinib
    Austria Czechia Denmark Germany Greece Hungary +5

  • Study of ibuzatrelvir alone or combined with remdesivir in adults with COVID-19 who have severely compromised immune systems

    Recruiting

    3 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • IBUZATRELVIR
    • Remdesivir
    Belgium Denmark France Germany Greece The Netherlands +3

  • Study of BMS-986368 to treat muscle stiffness in people with Multiple Sclerosis

    Recruiting

    2 1
    Czechia Germany Poland
Previous Page
1 … 158 159 160 161 162 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!